leadf
logo-loader
viewAnglo African Oil & Gas PLC

Anglo African Oil & Gas is actively reviewing acquisition opportunities

“The company is now actively seeking an acquisition of an asset or a company with the ability to increase value for shareholders," said Sarah Cope.

Anglo African Oil & Gas PLC -

Anglo African Oil & Gas PLC (LON:AAOG) told investors it is actively reviewing acquisition opportunities.

The company, which agreed to divest its assets in the Congo earlier this year, reported its interim results which included a £462,000 loss from continuing operations reduced from £2.21mln in 2019, with lower spend on staffing costs and overhead.

“With the sale of AAOGC the company continues to review and reduce overhead costs, as it seeks new opportunities,” said Sarah Cope, AAOG chair.

READ: Anglo African agrees new exit price

“The company is now actively seeking an acquisition of an asset or a company with the ability to increase value for shareholders and the board is actively reviewing opportunities.

“With the sale of its only asset in May 2020, the company is currently an AIM Rule 15 cash shell and is currently looking at opportunities for acquisitions that will establish a near term cash generating business in the natural resources sector.

“The board will keep shareholders informed of its progress on a regular basis.”

In June, the company entered into an unsecured convertible loan facility amounting to £1.5mln, with a first drawdown of £160,000.

Tuesday’s results noted that the company continues to discuss finance options with external investors and its major shareholder.

Quick facts: Anglo African Oil & Gas PLC

Price: 0.275 GBX

AIM:AAOG
Market: AIM
Market Cap: £1.37 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Amryt Pharma presents at the Proactive One2One virtual conference

Amryt Pharma's LON:AMYT) Rory Nealon presents at the Proactive One2One virtual conference. Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases. The company...

14 hours, 34 minutes ago

2 min read